fda d.i.s.c.o.: avelumab in merkel cell carcinoma
Published 5 months ago • 9 plays • Length 6:31Download video MP4
Download video MP3
Similar videos
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
0:35
dr. kudchadkar on the fda approval of avelumab in merkel cell carcinoma
-
1:06
managing avelumab side effects in patients with merkel cell carcinoma
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: fda approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma
-
1:34
javelin merkel 200: avelumab for metastatic merkel cell carcinoma
-
2:03
avelumab in merkel cell carcinoma – updates from asco 2017
-
0:38
dr. siefker-radtke on fda approval of avelumab in bladder cancer
-
5:55
targetting pd-l1 with avelumab in metastatic merkel cell carcinoma
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
2:18
durable responses to avelumab in patients with merkel cell carcinoma
-
1:42
dr. hamid on the fda approval of pembrolizumab in merkel cell carcinoma
-
2:43
bavencio (avelumab)- merkel cell carcinoma (mcc)
-
1:28
avelumab treatment in patients with metastatic merkel cell carcinoma
-
1:38
dr. lebbe discusses efficacy of avelumab in merkel cell carcinoma
-
7:01
fda approvals in ovarian cancer and merkel cell carcinoma
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer
-
5:50
beating merkel cell carcinoma with immunotherapy
-
0:46
merkel cell carcinoma development time lapse - more deadly than melanoma!